These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 8997599)

  • 1. SCH 23390: the first selective dopamine D1-like receptor antagonist.
    Bourne JA
    CNS Drug Rev; 2001; 7(4):399-414. PubMed ID: 11830757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of dopamine D
    Milienne-Petiot M; Groenink L; Minassian A; Young JW
    J Psychopharmacol; 2017 Oct; 31(10):1334-1346. PubMed ID: 28950781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotation and immediate-early gene expression in rats treated with the atypical D1 dopamine agonist SKF 83822.
    Wirtshafter D
    Pharmacol Biochem Behav; 2007 Mar; 86(3):505-10. PubMed ID: 17306871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats.
    Brioni JD; Moreland RB; Cowart M; Hsieh GC; Stewart AO; Hedlund P; Donnelly-Roberts DL; Nakane M; Lynch JJ; Kolasa T; Polakowski JS; Osinski MA; Marsh K; Andersson KE; Sullivan JP
    Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6758-63. PubMed ID: 15087502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated detection of the head-twitch response using wavelet scalograms and a deep convolutional neural network.
    Halberstadt AL
    Sci Rep; 2020 May; 10(1):8344. PubMed ID: 32433580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrexidine--the first full dopamine D1 receptor agonist.
    Salmi P; Isacson R; Kull B
    CNS Drug Rev; 2004; 10(3):230-42. PubMed ID: 15492773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR; Laruelle M; Mouradian MM
    J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: preclinical pharmacology and clinical data.
    Giardina WJ; Williams M
    CNS Drug Rev; 2001; 7(3):305-16. PubMed ID: 11607045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431.
    Shiosaki K; Asin KE; Britton DR; Giardina WJ; Bednarz L; Mahan L; Mikusa J; Nikkel A; Wismer C
    Eur J Pharmacol; 1996 Dec; 317(2-3):183-90. PubMed ID: 8997599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.
    Shiosaki K; Jenner P; Asin KE; Britton DR; Lin CW; Michaelides M; Smith L; Bianchi B; Didomenico S; Hodges L; Hong Y; Mahan L; Mikusa J; Miller T; Nikkel A; Stashko M; Witte D; Williams M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):150-60. PubMed ID: 8558425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1- ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431).
    Michaelides MR; Hong Y; DiDomenico S; Asin KE; Britton DR; Lin CW; Williams M; Shiosaki K
    J Med Chem; 1995 Sep; 38(18):3445-7. PubMed ID: 7658429
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of dopamine D1 receptor full agonists in rats trained to discriminate SKF 38393.
    Gleason SD; Witkin JM
    Behav Pharmacol; 2004 Feb; 15(1):85-9. PubMed ID: 15075630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA; Himmler C; Bonta T; Rice LL
    Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective dopamine D1 receptor agonist A-86929 maintains efficacy with repeated treatment in rodent and primate models of Parkinson's disease.
    Asin KE; Domino EF; Nikkel A; Shiosaki K
    J Pharmacol Exp Ther; 1997 Apr; 281(1):454-9. PubMed ID: 9103530
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.